Consolidated Income Statements (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Consolidated Income Statements
Gross sales	$ 23,750,749	$ 265,147	$ 48,039,951	$ 714,951
Program costs and discounts	(9,410,972)		(18,589,963)
Net sales	14,339,777	265,147	29,449,988	714,951
Costs of sales	8,318,669	87,128	17,688,709	233,607
Gross profit	6,021,108	178,019	11,761,279	481,344
Selling, general and administrative	7,290,471	305,606	17,357,722	605,451
Operating loss	(1,269,363)	(127,587)	(5,596,443)	(124,107)
Impairment of goodwill		2,488,708		2,488,708
Interest expense, net	411,718	256	1,015,766	781
Net loss	(1,681,081)	(2,616,551)	(6,612,209)	(2,613,596)
Net loss attributable to noncontrolling interest	(163,548)		(948,220)
Net loss attributed to CVSL	$ (1,517,533)	$ (2,616,551)	$ (5,663,989)	$ (2,613,596)
Basic and diluted loss per share:
Weighted average common shares outstanding (in shares)	487,712,326	441,358,097	487,712,326	439,184,771
Net loss per share attributable to CVSL (in dollars per share)		$ (0.01)	$ (0.01)	$ (0.01)